BRIM-1, -2 and -3 trials: improved survival with vemurafenib in metastatic melanoma patients with a BRAF V600E mutation
Young, Kate, Minchom, Anna, Larkin, JamesVolume:
8
Language:
english
Journal:
Future Oncology
DOI:
10.2217/fon.12.43
Date:
May, 2012
File:
PDF, 702 KB
english, 2012